Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026)
James A. Eastham(Memorial Sloan Kettering Cancer Center), Sheena Patel(Patel Hospital), Erin Kirkby(American Urological Association), Lauren J. Pak(American Urological Association), Alicia K. Morgans(Harvard University), George Rodrigues(London Health Sciences Centre), Carissa E. Chu(University of California, San Francisco), Daniel A. Barocas(Vanderbilt University Medical Center)
Cited by 5
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592